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Ventilatory and metabolic changes during high efficiency hemodialysis.
Ventilatory and metabolic changes were measured in seven patients
undergoing high efficiency hemodialysis using a cuprophane dialyzer
and bicarbonate-containing dialysate, At an HCO3 concentration of 35
mEqfliter and a mean in vivo urea clearance of 3.6 mI/kg/mm, hypox-
emia was not detected during dialysis (Pa02 was 14.00 and 13.60 kPa
before and during dialysis). The new findings, related to high efficiency
bicarbonate dialysis, include a sustained rise in minute ventilation (YE,
6.1 to 6.8 liter/mm, P < 0.01), an increase in CO excretion (VCO2, 194
to 214 mI/mm, P < 0.05), and 02 consumption (V02, 215 to 246 mI/mm,
P < 0.05). The increment in VE and VCO, was attributed to the high
flux rate of bicarbonate while the rise in V02 is likely the result of
metabolic alkalosis. Arterial pH rose from 7.40 to 7.49 mm Hg and
serum HCO3 increased from 23.8 to 29.2 mEq/liter, while pCO2
remained normal at 5.07 kPa throughout the study. The acid-base status
of the blood changed from that of a metabolic acidosis to that of a
respiratory acidosis across the dialyzer where the pH decreased from
7.47 to 7.41 and pCO2 rose from 5.31 to 7.72 kPa. These data indicate
that a healthy ventilatory response is needed to excrete the excess CO2
generated during high efficiency bicarbonate hemodialysis. The signif-
icance and etiology of the elevated 02 consumption is undetermined.
In the era of conventional hemodialysis, acetate was the
buffer base in dialysate and hypoxemia the most prevalent
respiratory change 11—SI. Such hypoxemia is primarily due to
CO2 loss across the dialyzer [6] with a minor contribution from
an increasing alveolar-arterial oxygen gradient due presumably
to leukocyte/platelet aggregates [2]. In this situation, hypox-
emia is accompanied by reduced minute ventilation [7]. With
the introduction of high efficiency hemodialysis and the use of
bicarbonate buffer, there is a rapid flux of bicarbonate from the
dialysate to the patient. We hypothesized that this flux would
generate excess CO2 and require an increase in ventilation to
maintain acid-base balance. This report focuses on the ventila-
tory and metabolic changes of high efficiency hemodialysis.
Methods
Study subjects and dialysis treatment
Seven hemodialysis patients were recruited for this study,
their demographic and clinical data are listed in Table 1. All
participants were clinically stable and without intercurrent
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illness. There were four women and three men, their ages
ranged from 20 to 55 years. Four patients had chronic glomer-
ulonephritis, and one each had hypertensive nephrosclerosis,
adult polycystic kidney disease, and medullary cystic kidney
disease. No patient had diabetes mellitus. Medications con-
sisted of phosphate binders and multivitamins; one subject (JD)
received enalaprilR. Renal replacement consisted of high effi-
ciency hemodialysis using the Gambro Single Pass Delivery
System with an ultrafiltration controller and bicarbonate dialy-
sate. Dialysis was performed three times a week and three
hours per session using new Gambro IC 6 N (1.6 m2) dialyzers
and bicarbonate dialysate ("Bicart," Cobe, Gambro, Hospal
Inc., Na = 142mEq/liter, K = 2 mEq/liter, Ca 3.25 mEq/liter,
Mg = 1 mEq/liter, CI = 101.5 mEq/liter, acetic acid = 3
mEq/liter, dextrose = 200 mg%, 11C03 38 mEq/liter). The
commercially purchased dialysate contains 38 mEq/liter of
bicarbonate and 3 mmol/liter of acetate; the bicarbonate con-
centration of the diluted dialysate, when measured, had a mean
value of 35 mEq/liter. Blood flow rate was 400 ml/min and
dialysate flow rate, 500 mI/mm. Mean in vivo urea clearance
derived from dialysate urea removal was 247 mI/mm (range 194
to 274). This resulted in derivation of a mean dialysis adequacy
index (Kt/V) of 1.16 using the single-pool variable-volume urea
kinetics (range 0.71 to 1.77) and a mean normalized protein
catabolic rate (NPCR) of 0.98 g'kg/day (range 0.67 to 1.41).
Both Kt/V and NPCR were calculated from the dialysis pre-
ceeding the experiment. Study dialyses were performed as
described but dialysis was shortened to two and one half hours.
Experimental design
Subjects were admitted to the Clinical Research Center and
studied the next morning after a 12 hour fast. Ventilation,
expired gas collections, and arterialized blood (obtained from
the arteriovenous fistula) samples were obtained every 30
minutes beginning two hours before and ending four hours after
completion of dialysis. Partial pressures of CO2 and 02 were
determined in blood and gas samples, and pH and HCO3 were
measured in blood samples.
Acute changes in acid-base status across the dialyzer were
examined by measuring pH, PCO2 and HCO3 in blood and
dialysate samples obtained simultaneously proximal and distal
to the dialyzer at 60 and 120 minutes during dialysis in four
subjects, Transfer of CO2 in gaseous form across the dialyzer
was calculated from the following [8, 91:
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Table 1. Demographic and dialysis status of the study subjects
Subject Age/sex
Ht/wt
rn/kg Kt/V
NPCR
g/kg/day
IA 56/F 1.61/76.7 1.31 0.98
JD 32/M 1.93 76.5 0.71 0.77
EB 54/F 1.64/83.6 1.36 1.41
TD 23/F 1.53/40.3 1.77 1.14
RF 46/M 1.81/87.8 0.86 0.97
VM 39/F 1.60/55.8 1.11 0.81
RS 20/M 1.68/54.5 1.02 0.94
Kt/V is dialysis adequacy index calculated by single compartment
variable volume kinetics, and NPCR is protein catabolic rate normal-
ized for a standard urea volume of 58% of body weight, as follows:
NPCR = PCR/ (V/0.58).
CO2 (mmol/liter) = (zpCO2IBP) x (0.533/25.6)
Where pCO2 is difference in CO2 tension across the dia-
lyzer, BP is the barometric pressure (STPD), 0.533 is the CO2
solubility coefficient, and 25.6 is Avogadro's constant stating
that one mole of CO2 occupies a volume of 25.6 liters at 38°C.
The protocol was approved by the Committee on Human
Research of the University of Iowa College of Medicine.
Indirect ca/orimetly
Respiratory gas exchange, including 02 consumption and
CO2 production, was determined by a portable metabolic Gas
Monitor (MGM II, Utah Medical Products, Midvale, Utah,
USA). During measurement, a mouth piece attached to a
two-way valve was used. Expired gas was sampled by a small
gas line leading from the mouth piece to a zirconium-oxide 02
analyzer and an infra-red CO2 sensor. Simultaneously, tidal
volume and frequency of respiration were recorded by a pneu-
motacograph and an ultrasonic flow transducer. Partial pres-
sures of the inspired 02 and CO2 were derived from the
atmosphere. yE, VO2 and VCO2 were calculated by standard
equations and corrected for STPD. Before each experiment, the
equipment was calibrated with a reference gas standard con-
sisting of 21% 02 and 10% CO2 and the flow transducer was
checked by a calibrated syringe [10, 111.
Data were stored in the clinfo system and were examined by
one-way analysis of variance and Duncan's multiple compari-
son test as well as paired t-test when appropriate.
Results
Figure 1 and Table 2 summarize ventilatory changes during
high efficiency hemodialysis. Minute ventilation increased from
a baseline of 6.1 to 6.8 liter/mm within 30 minutes after initiating
dialysis and remained elevated during and for four hours
following dialysis. Similarly, CO2 production (VCO2) increased
from a basal value of 194 mI/mm to 214 and 218 ml/min during
and after dialysis, respectively. Oxygen consumption (V02)
which was 215 mI/mm in the basal state, rose to 226 and 246
mI/mm during and after dialysis, respectively.
Figure 2 and Table 3 depict changes in the patient's acid-base
parameters. Initiating dialysis resulted in a prompt rise in pH,
from 7.40 to 7,48 and 7.49 during and after dialysis, respec-
tively. Likewise serum bicarbonate rose from 24 mEq/liter
pre-dialysis to 29 mEq/liter during and after dialysis. In the face
of significant alkalosis, pCO2 remained normal and remarkably
stable at 5.07 to 5.20 kPa throughout the observation period.
Arterial oxygen tension (PO2) which was normal (14.00 kPa)
before dialysis, remained so (13.60 kPa) during dialysis, but was
reduced to 11.73 kPa three to four hours following dialysis.
Despite the reduced oxygen tension, 02 saturation remained
excellent at 97%. The (A-a)O2 gradient (Table 3) which was 5.6
mm Hg in the pre-dialysis period, rose modestly and progres-
sively to 12.1 mm Hg during and 16.5 mm Hg at the end of the
study. It should be noted that only one of our study subjects had
a pre-dialysis serum bicarbonate level below 23 mEq/liter and
arterial pH was equal to or above 7.35 in all.
Table 4 and Figure 3 summarize and depict acid-base changes
across the dialyzer. Dialysis against a delivered bicarbonate
concentration of 35 mEq/liter resulted in a marked rise in pCO2
(kPa) from 5.31 in the arterial blood entering the dialyzer to 6.72
in the venous blood returning to the patient. Serum bicarbonate
(mEq/liter) increased from 29 in the arterial inlet to 32 in the
venous outlet. Because the rise in pCO2 was proportionately
greater than that of the bicarbonate, the pH of the blood
returned to the patient was reduced to 7.41, while the systemic
arterial pH was 7.47. Analysis made in the dialysate compart-
ment showed diametric changes; HCO3 was reduced from 34.8
to 32 mEq/liter and pCO2 from 8.30 to 6.52 kPa, causing the
dialysate to become more alkaline as it passed through the
dialyzer.
During dialysis, patients gained CO2, from CO2 dissolved in
the dialysate at a rate of 0.24 mmol/min or 6.3 mI/mm. While the
pCO2 difference across the dialyzer was constant throughout
dialysis, the HCO3 gradient across the dialyzer was not; it was
large in the beginning and fell with time. During its passage
through the dialyzer, the blood gained 02 from the dialysate;
the amount transferred was, however, less than 3 ml/min,
calculated from hemoglobin level, 02 saturation and P°2•
Discussion
When acetate is used as the buffer base during hemodialysis,
the fall in arterial oxygen pressure is usually modest, ranging
from 10 to 15% of baseline value, though arterial P°2 may be
reduced to as low as 9.33 kPa in subjects without pulmonary
disease. The prevailing view believes that such hypoxemia is
largely the result of CO2 and bicarbonate loss across the
dialyzer with secondary reduction in minute ventilation. This
concept is supported by abundant data showing a reduction in
pCO2 and VCO2 during dialysis [6, 7, 12—16] and elimination
[17—21] or attenuation [22, 23] of dialysis-induced hypoxemiaby
substituting bicarbonate for the acetate buffer. There are,
however, reports showing significant P°2 reductions with bi-
carbonate dialysate [12—16]. The reason for such discrepancy is
not clear. In the current study, we found that bicarbonate
dialysate obviated the development of hypoxemia during hemo-
dialysis despite use of a complement-activating membrane. This
underscores CO2 loss as the primary cause of hypoxemia
associated with acetate dialysate and minimizes the role of
ventilation/perfusion mismatching or shunt resulting from al-
tered pulmonary perfusion.
The minimal reduction in P°2 to 11.73 kPa following comple-
tion of dialysis in our patients could not be explained by
abnormal ventilation since the dead space to tidal volume ratio
remained constant, nor on the basis of respiratory suppression
by metabolic alkalosis because there was no evidence of
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Table 2. Ventilatory changes associated with high efficiency
heniodialysis
Period
Vco2 Vo2 VE
liter/mm VCO2/V02mi/mm
Pre-HD 194 47 215 47 6.11 1.75 0.90 0.10
HD 214 453 226 40 6.86 l.93 0.94 0.09
Post-liD 218 Si3 246 52" 6.89 2.13' 0.89 0.10
ANOVADF 115
F 2.40 4.43 1.60 3.03
P 0.095 0.014 0.207 0.05
All values are listed as means so, Vco2, V02 and VE represent,
respectively, CO2 excretion, oxygen consumption and minute ventila-
tion. Pre-HD, liD, and Post-liD represent the mean of each subject's
mean pre- (N = 5), intra- (N = 5), and post-dialysis (N = 8) values. tn
the analysis of variance, degree of freedom (DF), F and P values are
listed for each parameter. "and b represent, respectively, P values of <
0.05 and c 0.01 comparing HD and post-HD to pre-HD values by paired
i-test.
hypoventilation. In fact, minute ventilation was increased and
pCO2 remained normal. Hunt and colleagues also noted persist-
ent hypoxemia post-dialysis and postulated several potential
mechanisms, including intra-pulmonary leukostasis, decreased
cardiac output and micro-atelectasis [11]. The time course of
this hypoxemia is inconsistent with complement activated leu-
kostasis which occurs within 30 to 60 minutes of dialysis
initiation. The late and prolonged fall of p02 associated with a
rising arterial to alveolar oxygen gradient is most consistent
with the hypothesis that micro-atelectasis of recumbency rather
than dialysis causing the fall in p02. Most patients undergoing
this type of study are recumbent; our study subjects specifically
had been in bed for sixteen hours by the experiments' comple-
tion. The increase in (A-a)02 gradient from a baseline of 6 to 16
mm Hg post-dialysis is consistent with such speculation, none-
theless, the possibility of a delayed onset of ventilation/perfu-
sion mismatch cannot be excluded.
The respiratory exchange ratio is generally reduced with
acetate and normal with bicarbonate dialysate [7, 14, 15]. The
Fig. 1. Ventilatory changes during high
efficiency hemodialysis. Values are depicted
as means 5EM. Hemodialysis led to an
increase in minute ventilation EVE, -&] and
CO2 excretion [VCO2, ej. 02 consumption[V02, --] was increased in the post-dialysis
period.
former is, in part, due to an increased oxygen consumption
associated with acetate metabolism [241. By contrast, we found
a significant rise in the respiratory quotient during dialysis and
we are attributing this increase to oxidative metabolism of
dialysate glucose.
As expected, hemodialysis increased the serum bicarbonate
concentration and the blood pH. Despite enormous shifts in pH
and HCO3, pCO2 remained normal with virtually no fluctuation
throughout the study period (Fig. 2). This observation stresses
the exquisite sensitivity of the respiratory center in regulating
pCO2. The absolute HCO3 gain is difficult to quantitate because
bicarbonate space is not static during and immediately post-
dialysis and because a significant amount of bicarbonate is lost
through ultrafiltration.
While arterial pCO2, CO2 production rate, and minute venti-
lation are reduced with acetate-containing dialysate, they are
generally reported to be normal when bicarbonate is substituted
for acetate [7, 12, 14, 15, 181. In the current study, we found
that the combination of bicarbonate dialysate and high effi-
ciency hemodialysis generated substantial quantities of CO2 gas
which then stimulated respiration as evidenced by a 13%
increase in minute ventilation (YE) and CO2 production. We
believe the rise in VCO2 is primarily due to bicarbonate
metabolism and subsequent CO2 generation, not transfer of
dissolved CO2 from the dialysate [251. The calculated gain of
gaseous CO2 (Table 4, blood compartment) was only 0.13
mmol/min or 3.3 mI/mm, which was 1.7% of the basal CO2
production rate. It should be emphasized that the increase in
VCO2 and VE persisted for at least four hours following
completion of hemodialysis. Since alkalosis generally inhibits
respiration, the need to acutely excrete excess CO2 delivered
during dialysis apparently overrode this inhibition. This sug-
gests that the need to excrete the excess CO2 takes precedence
over the need to maintain a normal pH. Alternatively, the lack
of respiratory inhibition during bicarbonate dialysis may, in
pan, be due to the relative difficulty with which bicarbonate
penetrates blood-brain and cellular barriers allowing CO2 to
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Table 3. Changes in arterial blood gases with high efficiency hemodialysis
% SatPeriod pH mm Hg
Pre-HD 7.404 0.049 38 3 105 16 23.8 3.4 97.7 1.1 5.63 7.20
HD 7.484 ØØ57 39 3 102 23 29.2 3.1 97.8 1.2 12.09 10.68
Post-HD 7.494 0.038a 38 3 88 4a 29.2 2.6a 97.0 1.4 16.46 12.75
ANOVADF 60
F
P
15.92
0.003 x lO
0.37
0.69
5.36
0.007
16.29 -
0.002 x 10
2.39
0.100
3.95
0.02
All values are means sn. Results of analysis of variance, including degree of freedom, F and P values are listed under each parameter.
(A — a)02 indicates alveolar-arterial P°2 gradient or PAO2 — Pa02. PAO2 = Pi02 — PaCO2 x {FiO + RI — Fi02)/R]}
a p < 0.01 by paired 1-test comparing the mean of the intra- and post-dialysis values to the mean of the pre-dialysis values
diffuse into these cells and produce an intracellular acidosis [26,
27] in the presence of an extracellular alkalosis.
Changes in acid-base status across the dialyzer, including
influx of bicarbonate and dissolved CO2 into the blood, are
predictable. The change in pH was unexpected; blood returning
to the patient was more acidic than that entering the dialyzer,
and the spent dialysate was more alkaline than the fresh
solution. These paradoxes were best explained by the prepon-
derant or greater magnitude of change in pCO2 versus bicar-
bonate. Thus, blood enters the extracorporeal circuit with
findings of a metabolic acidosis, and is returned to the patient
with values reflecting a respiratory acidosis.
It is important to emphasize that an adequate ventilatory
capacity is imperative to excrete the excess CO2 generated
during high efficiency bicarbonate hemodialysis. In patients
whose respiratory function is compromised or in whom venti-
lation is fixed during mechanical ventilation, bicarbonate load-
ing poses the risk of hypercarbia and respiratory acidosis.
While Bouffard et al did not find an elevated pCO2 during
bicarbonate dialysis in sedated, mechanically ventilated pa-
tients [28], their study permitted wide variations in minute
ventilation, and the dialysate bicarbonate concentration was
much lower than that currently in use. Moreover, their dialysis
efficiency was probably lower than that achieved by high
efficiency hemodialysis. Further increases in dialysis efficiency
will accentuate the acid-base disturbances of rapid bicarbonate
administration and may precipitate transient respiratory acido-
sis,
Increased oxygen consumption with hemodialysis is gener-
ally reported with acetate [24], but not recognized with bicar-
bonate dialysate. We are attributing the rise in V02observed in
our subjects to the development of a metabolic alkalosis.
C,)
35 30 15 7.50
30 20 10 7.45
25 10 5 7.40
20 0 0 7.35 i. _JLP..T. Fig. 2. Changes in acid-base status during• • high efficiency hemodialysis. Values are
0 60 1 20 1 50 presented as means SEM. Hemodialysis
resulted in an increase in arterial pH (•) and0 60 120 180 240 serum HCO3 (-U-); pCO2 (A), however,
remained normal, and P°2 (-0-) was slightly
Time, minutes reduced in the post-dialysis period.
pCO2 P°2 HCO3
mEqIL
(A — a)02
mm Hg
1068 Symreng et a!: Hemodialysis and ventilation
Table 4. Acid-base changes across the dialyzer analyzed from blood and dialysate compartments
Fig. 3. Changes in acid-base status across the dialyzer. In the blood
compartment, HCO3 () and pCO2 (-A) rose whereas pH (G)
decreased. By contrast, in the dialysate compartment, HCO3 and pCO2
were reduced, and pH actually rose.
Arterial pH rose from 7.40 in the baseline to 7.48 and 7.49
during and after dialysis. High oxygen uptake during hyperven-
tilation is well recognized [29—31]. This increase in oxygen
consumption is independent of the mechanical work of breath-
ing, since it is observed in subjects whose respiratory muscles
are paralyzed and who are ventilated mechanically. It is be-
lieved that a fall in intracellular hydrogen concentration leads to
enhanced ATP hydrolysis and oxidative metabolism by stimu-
lating the activity of phosphofructokinase, the rate-limiting
enzyme involved in the glycolytic pathway rather than stimu-
lating lactate production [32, 331. The physiologic significance
of this increase in oxygen consumption associated with high
efficiency dialysis is yet to be determined.
In summary, similar to other studies, we note that using
bicarbonate dialysate eliminated hypoxemia. With regard to
ventilation, we found significant increases in minute ventilation
and CO2 excretion. Such increments are best explained by the
bicarbonate flux from the dialysate to the patient and the
subsequent CO2 generation following bicarbonate neutraliza-
tion. This increased CO2 production would lead to hypercarbia
if a compensatory rise in minute ventilation (VE) did not occur.
Failure of alkalosis to suppress respiration may, in part, be
explained by the difficulty with which bicarbonate penetrates
cellular and blood brain barriers. Metabolic alkalosis, neverthe-
less, resulted in increased oxygen consumption, a phenomenon
that is not generally recognized in dialysis patients.
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